Some of the products that company's will shoiwcase at this year's ESCRS.
CROMA will focus on the protection of the corneal surface during and after surgery. Hydration and protection of the cornea during surgical procedures are achieved with CORNEA_PROTECT® sterile single-dose units. HYLO-CARE® is a preservative-free therapeutic combination of sodium hyaluronate and dexpanthenol for the hydration and support of an enhanced healing process of the epithelium.
CROMA is performing research in the field of biomolecules and has developed the THIOMERS, a unique technology combining macromolecules, such as hyaluronic acid, with human amino acid (cysteine) for novel ophthalmic applications. In the field of dry eye, the THIOMER-based biopolymers will be able to covalently bind to the corneal surface and form a protective layer for more than 22 hours. This technology will be presented during CROMA´s satellite symposium.
What's new in retina
SLT in review of a decade
The introduction of Selective Laser Trabeculoplasty (SLT) represented the first fundamental change in laser treatment for open-angle glaucoma in many years. Following a decade of scientific and clinical experience, Lumenis has gathered a team of leading experts to discuss and debate the role of this unique technology. The faculty will address topics such as the current role of SLT in glaucoma management, how and when to apply the technology, patient selection and success predictors, long-term efficacy, repeatability, the most up-to-date clinical treatment protocol to ensure successful outcomes, and more.